I agree, pivalde. One can almost hear the scrambling from here. Or perhaps that's the sound of pharma reps running to their airports.
Let's not lose sight of the fact that this so-called "problem" is exactly the sort of problem of which every biotech investor dreams--"my inexpensive little biotech has had a great success and hardly anyone seems to know but me! Oh dear! What should I do!? "
PBT2 from the Doherty Institute news site., page-25
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
